Addex Therapeutics Ltd
Addex Therapeutics Ltd (ADXN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ADXN · as of Jun 8, 2026
Key Statistics
Explore Addex Therapeutics Ltd Data
adxn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The ADXN analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $30.00, representing +411.95% upside from the current price of $5.86.
Competitors & Peers
adxn competitorsADXN
ADIL
BCLI
CDIO
IBO
MTNBStock Performance
Full HistoryAbout Addex Therapeutics Ltd
Addex Therapeutics Ltd a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting …
what is addex therapeutics ltd · adxn stock overview · addex therapeutics ltd company profile · who is addex therapeutics ltd ceo · adxn NASDAQ · addex therapeutics ltd headquarters · addex therapeutics ltd business segments
About Stock Overview & Key Data
Addex Therapeutics Ltd (ADXN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 12, 2020. As of the latest trading session, ADXN stock price is $5.86, with a market capitalization of $4.2M. The stock has returned -31.41% over the past 12 months and -10.62% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Addex Therapeutics Ltd stock is Buy, with an average 12-month price target of $30.00. In fiscal year 2025, Addex Therapeutics Ltd reported revenue of $29972.00 and net income of -$6.7M. For detailed data — including Addex Therapeutics Ltd revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Addex Therapeutics Ltd (ADXN) stock price is $5.86. The stock is traded on NASDAQ under the ticker symbol ADXN. The 52-week range is $5.41 – $12.05.